img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
March 30, 2023
img
img
YanGuFang International Group Co., Ltd.
(Nasdaq: YGF)

$8,000,000

Initial Public Offering
Sole Bookrunner

March 29, 2023
img
img
Maxpro Capital Acquisition Corp. Merger with Apollomics Inc.
(Nasdaq: APLM)

~$919,000,000


Capital Markets Advisor

March 23, 2023
img
img
Oak Woods Acquisition Corporation
(Nasdaq: OAKUU)

$57,500,000

SPAC IPO
Sole Bookrunner

March 22, 2023
img
img
Four Leaf Acquisition Corporation
(Nasdaq: FORLU)

$54,210,000

SPAC IPO
Sole Bookrunner

March 13, 2023
img
img
Reliance Global Group, Inc.
(Nasdaq: RELI)

$4,000,000

Private Placement
Exclusive Placement Agent

March 7, 2023
img
img
Lionheart III Corp. Merger with Security Matters Ltd.
(Nasdaq: SMX)

~$225,000,000

Business Combination
Financial Advisor

March 6, 2023
img
img
Unicycive Therapeutics, Inc.
(Nasdaq: UNCY)

$30,000,000

Private Placement
Exclusive Placement Agent

March 1, 2023
img
img
Treasure Global Inc.
(Nasdaq: TGL)

$5,500,000

Private Placement
Exclusive Placement Agent

February 15, 2023
img
img
Maxpro Capital Acquisition Corp.
(Nasdaq: JMACU)

$23,650,000

Private Placement
Exclusive Placement Agent

February 14, 2023
img
img
Ocean Biomedical, Inc. Merger with Aesther Healthcare Acquisition Corp.
(Nasdaq: OCEA)

$274,875,000


Capital Markets Advisor

February 10, 2023
img
img
Hempacco Co., Inc.
(Nasdaq: HPCO)

$7,245,000

Underwritten Public Offering
Joint Bookrunner

February 9, 2023
img
img
Pono Capital Three, Inc.
(Nasdaq: PTHRU)

$115,000,000

SPAC IPO
Sole Bookrunner

1 … 9 10 11 12 13 … 34
Insights
  • April 9, 2025

    D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in connection with its $4.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 27, 2025

    D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

    Read More icon Read More icon
  • March 26, 2025

    D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

    Read More icon Read More icon
  • March 4, 2025

    D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

    Read More icon Read More icon
img
View All

Together, let's build meaningful value.